HBV Reactivation Rare After Stopping Tenofovir
NEW late-breaking data presented at the 2025 European AIDS Clinical Society (EACS) Congress indicate that stopping tenofovir in people with HIV who have past hepatitis B exposure poses little…
Category: 6. Health
-
Over 800 dengue cases recorded in southern Pakistan so far in 2025-Xinhua
ISLAMABAD, Oct. 16 (Xinhua) — As many as 819 dengue cases were recorded in Pakistan’s southern Sindh province so far this year, the Sindh Health Department said on Thursday.
A total of 175 new cases were reported so far in October, said the…
Continue Reading
-
Alcohol Consumption, Even In Small Amounts, Increases Dementia Risk
The research counters long-held beliefs that light intake of alcohol could be beneficial for health and instead suggests that it can increase the risk of dementia and cancer. Other news is on the improving obesity…
Continue Reading
-
Usability of serum receptor-interacting protein kinase-1 as a biomarke
Introduction
Aneurysmal subarachnoid hemorrhage (aSAH), the most common type of subarachnoid hemorrhage (SAH), accounts for approximately 85% of all cases. It is characterized by high disability and mortality rates, and gravely imposes the social…
Continue Reading
-
SPIRAL device offers safer, smarter drug delivery to the brain
Scientists have created a flexible brain implant, called SPIRAL, capable of delivering drugs to multiple regions with pinpoint accuracy.
Researchers at NYU Abu Dhabi (NYUAD) have designed a new type of brain implant that can…
Continue Reading
-
Toripalimab Plus CCRT Generates 100% ORR, But Safety Concerns Warrant Additional Research in Locally Advanced Cervical Cancer
The addition of toripalimab-tpzi (Loqtorzi) to concurrent chemoradiotherapy (CCRT) led to an overall response rate (ORR) of 100% (95% CI, 85.9%-100%) in patients with locally advanced cervical cancer, according to data from a phase 1b trial…
Continue Reading
-
Johnson & Johnson receives U.S. FDA Priority Review for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) in BRCA-mutated metastatic castration-sensitive prostate cancer
HORSHAM, PA, October 16, 2025 – The U.S. Food and Drug Administration (FDA) granted Priority Review to Johnson & Johnson for its supplemental New Drug Application (sNDA) for AKEEGA® (niraparib and abiraterone…
Continue Reading
-
Pharmacokinetics and safety of fospropofol disodium for injection in s
Introduction
The liver serves as the principal organ for drug elimination, orchestrating critical metabolic pathways, including oxidation, reduction, and conjugation, that govern the pharmacokinetics (PK) of intravenous anesthetics.1,2 Hepatic…
Continue Reading
-
Deep Sedation During Ventilation Can Cost Patients Their Independence, Study Says | Health
Deep Sedation During Ventilation Can Cost Patients Their Independence, Study Says | Health | nbcrightnow.com
We recognize you are attempting to access this website from a…
Continue Reading
